Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, January 11, 2021
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
[ Mon, Jan 11th 2021
] - WOPRAI
Sun, January 10, 2021
[ Sun, Jan 10th 2021
] - WOPRAI
[ Sun, Jan 10th 2021
] - WOPRAI
[ Sun, Jan 10th 2021
] - WOPRAI
Fri, January 8, 2021
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
[ Fri, Jan 08th 2021
] - WOPRAI
Danielle Brill Downgraded (SRPT) to Hold on, Jan 8th, 2021
Danielle Brill of Raymond James, Downgraded "Sarepta Therapeutics, Inc." (SRPT) to Hold on, Jan 8th, 2021.
Danielle has made no other calls on SRPT in the last 4 months.
There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 0 agree with Danielle's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Danielle
- Colin Bristow of "UBS" Initiated at Strong Buy and Held Target at $212 on, Wednesday, October 28th, 2020
- Joel Beatty of "Citigroup" Maintained at Strong Buy with Increased Target to $190 on, Tuesday, September 15th, 2020
